ADVAXIS INC (ADXS) Stock Price, Quote, News and Overview
NASDAQ:ADXS - Nasdaq - Common Stock
ADXS Quote, Performance and Key Statistics
NASDAQ:ADXS (12/23/2021, 11:39:10 AM)
0.155
-0.08 (-35.42%)
The current stock price of ADXS is 0.155 null. In the past month the price decreased by -61.41%. In the past year, price decreased by -59.74%.
ADXS Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About ADXS
Company Profile
Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. The company is headquartered in Monmouth Junction, New Jersey and currently employs 18 full-time employees. The company went IPO on 2005-07-28. The firm is using its Lm platform directed against tumor-specific targets to engage the patient's immune system to destroy tumor cells. These immunotherapies are based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins. Its Lm platform technology has clinical activity in several programs. These Lm strains integrate multiple functions into a single immunotherapy as they access and direct antigen presenting cells to stimulate anti-tumor T-cell immunity, stimulate and activate the immune system with the equivalent of multiple adjuvants, and simultaneously reduce tumor protection in the tumor microenvironment (TME) to enable the T-cells to eliminate tumors.
Company Info
ADVAXIS INC
9 Deer Park Drive, Suite K-1
Monmouth Junction NEW JERSEY 08540 US
CEO: Kenneth Berlin
Employees: 18
Company Website: https://www.advaxis.com/
Phone: 17325451590.0
ADVAXIS INC / ADXS FAQ
What is the stock price of ADVAXIS INC today?
The current stock price of ADXS is 0.155 null. The price decreased by -35.42% in the last trading session.
What is the ticker symbol for ADVAXIS INC stock?
The exchange symbol of ADVAXIS INC is ADXS and it is listed on the Nasdaq exchange.
On which exchange is ADXS stock listed?
ADXS stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ADVAXIS INC stock?
7 analysts have analysed ADXS and the average price target is 2.3 null. This implies a price increase of 1380.65% is expected in the next year compared to the current price of 0.155. Check the ADVAXIS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ADVAXIS INC worth?
ADVAXIS INC (ADXS) has a market capitalization of 22.57M null. This makes ADXS a Nano Cap stock.
How many employees does ADVAXIS INC have?
ADVAXIS INC (ADXS) currently has 18 employees.
Should I buy ADVAXIS INC (ADXS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ADXS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ADXS, evaluating the profitability, health, valuation and growth aspects
- ADVAXIS INC (ADXS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ADVAXIS INC (ADXS) Sales and EPS estimates to see what analysts future expectations are.
- ADVAXIS INC (ADXS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ADVAXIS INC (ADXS) Insider and Institutional Ownership to learn about the owners and their transactions.
- ADVAXIS INC (ADXS) Stock Chart to make your own analysis
- ADVAXIS INC (ADXS) Latest news and press-releases to stay up to date.
Does ADVAXIS INC (ADXS) stock pay dividends?
ADXS does not pay a dividend.
When does ADVAXIS INC (ADXS) report earnings?
ADVAXIS INC (ADXS) will report earnings on 2022-04-01, before the market open.
What is the Price/Earnings (PE) ratio of ADVAXIS INC (ADXS)?
ADVAXIS INC (ADXS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.2).
What is the Short Interest ratio of ADVAXIS INC (ADXS) stock?
The outstanding short interest for ADVAXIS INC (ADXS) is 0% of its float. Check the ownership tab for more information on the ADXS short interest.
ADXS Technical Analysis
ADXS Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ADXS. ADXS may be in some trouble as it scores bad on both profitability and health.
ADXS Financial Highlights
Over the last trailing twelve months ADXS reported a non-GAAP Earnings per Share(EPS) of -0.2. The EPS increased by 58.75% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -581.85% | ||
| ROA | -37.01% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
ADXS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to ADXS. The Buy consensus is the average rating of analysts ratings from 7 analysts.